RE: Feeling confident for Med & L/term21 May 2019 16:55
I am no expert on how targets are supposed to be announced but my take has been from previous years that they worked with/informed the House Broker.
I believe there is no need for them to formally announce anything unless they expect more than 10% variance from the target which at 13.2m falls within that tolerance level. As I say I dont know this tolerance rule as a fact just going by what others have posted. If you want to get it confirmed yourself, then it should be easy enough to get it directly confirmed by talking to the PR Company.
On your numbers, I am not sure how you got £2m from for Roots given the H1 number was £265k I believe. I do think that SkinnyTan will be higher at around 10.5 to 11.0m with the rest from Roots, C+L etc. I think all the other products wont be material at all for this year. Good news though, is that we hav eth egrowth on these to leverage for next year!
If skinnyTan comes in at 10m then mcap for just SkinnyTan should imo be £20m. and every additional 1m would be worth another circa £4m to the mcap I reckon. I'm basing that on what we know St Tropez sold for back in 2010. That all said, I am hoping for £11m for Skinny Tan this year.
Re ProLong, I am not convinced that things are going so well there with that one - its way late, we havent heard anything on it and I am yet to be convinced that IDP can get the sales volumes that justify Haris having paid over £1m for it, not to mention the royalty payments and consultancy fees. That said, if they can finally get this off the ground and show they can grow revs with it then very happy days indeed.
If they can deliver half-decent numbers this year then I will be very optimistic (like VERY) for the prospects of IDP over the next 12 to 24 months.